About Business
Linahert 5 by Hertz Pharma is a targeted oral medication formulated to support individuals living with Type 2 Diabetes. Each tablet contains Linagliptin 5 mg, a DPP-4 inhibitor that works by increasing incretin levels in the body, helping to regulate insulin secretion and suppress excess glucose production. This mechanism offers effective blood sugar control without causing weight gain and with a reduced risk of hypoglycemia. Linahert 5 is particularly suitable for patients who require monotherapy or are transitioning to combination therapies under medical supervision.
Backed by Hertz Pharma’s commitment to innovation and patient care, Linahert 5 is manufactured in WHO-GMP certified facilities, ensuring consistent quality and safety. Its once-daily dosage makes it a convenient option for long-term diabetes management, promoting better treatment adherence. As part of a comprehensive care plan, Linahert 5 empowers patients and healthcare providers alike to achieve more stable glycemic control and improved overall well-being.
Add a review